The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT-Reference-Cited by-同舟云学术

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

Published:2013-06-17 Issue:11 Volume:48 Page:1409-1414
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Robinson S P,Canals C,Luang J J,Tilly H,Crawley C,Cahn J Y,Pohlreich D,Le Gouill S,Gilleece M,Milpied N,Attal M,Biron P,Maury S,Rambaldi A,Maertens J,Capria S,Colombat P,Montoto S,Sureda A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201383.pdf

Reference37 articles.

1. Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnsen H et al. High dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomised European CUP trial. J Clin Oncol 2003; 21: 3918–3927.

2. Montoto S, Canals C, Rohatiner AZS, Taghipour G, Sureda A, Schmitz N et al. Long term follow up of of high dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukaemia 2007; 21: 2324–2331.

3. Rohatiner AZS, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J et al. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remisssion: long-term follow-up. J Clin Oncol 2007; 25: 2554–2559.

4. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC et al. Incidence and characterisation of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dosee chemoradiotherapy and autologous stem cell transplantation for lymphoid malignancies. J Clin Oncol 1994; 12: 2527–2534.

5. Metayer C, Curtis RE, Vose JM, Sobocinski KA, Horowitz MM, Bhatia S et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicentre case-control study. Blood 2003; 101: 2015–2023.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation;Transplantation and Cellular Therapy;2024-09

2. Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-08

3. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature;Annals of Hematology;2024-03-02

4. Indolent Lymphoma;The EBMT Handbook;2024

5. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024